Building Blocks
Questa sezione contiene prodotti fondamentali per la sintesi di composti organici e biologici. Building blocks sono i materiali di partenza essenziali utilizzati per costruire molecole complesse attraverso varie reazioni chimiche. Svolgono un ruolo critico nella scoperta di farmaci, nella scienza dei materiali e nella ricerca chimica. Presso CymitQuimica, offriamo una gamma diversificata di building blocks di alta qualità per supportare le tue ricerche innovative e progetti industriali, assicurandoti di avere i componenti essenziali per una sintesi di successo.
Sottocategorie di "Building Blocks"
- Acidi boronici e derivati dell'acido boronico(5.756 prodotti)
- Building Blocks Chirali(1.242 prodotti)
- Building Blocks Idrocarburici(6.095 prodotti)
- Building Blocks organici(61.051 prodotti)
Trovati 199813 prodotti di "Building Blocks"
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
3-Ethoxyspiro[3.4]octan-1-ol
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H18O2Purezza:Min. 95%Peso molecolare:170.25 g/mol1-(1,4-Dimethylpiperazin-2-yl)ethan-1-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H19N3Purezza:Min. 95%Peso molecolare:157.26 g/mol2-(2-Ethylphenoxy)-1-(piperazin-1-yl)propan-1-one hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C15H23ClN2O2Purezza:Min. 95%Peso molecolare:298.81 g/mol1-(1H-1,3-Benzodiazol-2-ylmethyl)piperidin-4-amine trihydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H21Cl3N4Purezza:Min. 95%Peso molecolare:339.7 g/mol2,2,5-Trimethylhexan-3-amine hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H22ClNPurezza:Min. 95%Peso molecolare:179.73 g/mol(1R)-1-(Pyrazin-2-yl)ethan-1-ol
CAS:<p>Versatile small molecule scaffold</p>Formula:C6H8N2OPurezza:Min. 95%Peso molecolare:124.14 g/mol(1S)-1-(Pyrazin-2-yl)ethan-1-ol
CAS:<p>Versatile small molecule scaffold</p>Formula:C6H8N2OPurezza:Min. 95%Peso molecolare:124.14 g/mol{4-[(2-Oxo-1,2-dihydropyridin-1-yl)methyl]phenyl}boronic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H12BNO3Purezza:Min. 95%Peso molecolare:229.04 g/mol5H,6H,7H,8H-Pyrido[4,3-c]pyridazin-3-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H10N4Purezza:Min. 95%Peso molecolare:150.18 g/mol1-(Propan-2-yl)-4,5,6,7-tetrahydro-1H-indazol-6-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H17N3Purezza:Min. 95%Peso molecolare:179.26 g/molPotassium [(4-chlorophenyl)methyl]trifluoroboranuide
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H6BClF3KPurezza:Min. 95%Peso molecolare:232.48 g/mol3-Amino-4-(3,4-difluorophenyl)-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]butan-1-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C16H16F5N5OPurezza:Min. 95%Peso molecolare:389.32 g/mol1-(2-(Bromomethyl)phenyl)propan-2-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H11BrOPurezza:Min. 95%Peso molecolare:227.1 g/mol5,6-Dimethyl-1-benzofuran-3-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H10O3Purezza:Min. 95%Peso molecolare:190.19 g/mol[2-(4-Fluorophenoxymethyl)phenyl]boronic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H12BFO3Purezza:Min. 95%Peso molecolare:246.04 g/mol[5-Fluoro-2-(oxolan-3-ylmethoxy)phenyl]boronic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H14BFO4Purezza:Min. 95%Peso molecolare:240.04 g/mol4,8-Dichloroimidazo[1,5-a]quinoxaline
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H5Cl2N3Purezza:Min. 95%Peso molecolare:238.07 g/moltert-Butyl N-methyl-N-(pyrrolidin-2-ylmethyl)carbamate
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H22N2O2Purezza:Min. 95%Peso molecolare:214.3 g/mol[4-(Oxolan-3-ylmethoxy)phenyl]boronic acid
CAS:Versatile small molecule scaffoldFormula:C11H15BO4Purezza:Min. 95%Peso molecolare:222.05 g/mol[2-(But-3-en-1-yloxy)phenyl]boronic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H13BO3Purezza:Min. 95%Peso molecolare:192.02 g/moltert-Butyl 4-(2-aminoethyl)-3,3-difluoropiperidine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H22F2N2O2Purezza:Min. 95%Peso molecolare:264.31 g/moltert-Butyl 3,3-difluoro-4-(2-hydroxyethyl)piperidine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H21F2NO3Purezza:Min. 95%Peso molecolare:265.3 g/mol3,3-difluoropiperidin-4-ol hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C5H10ClF2NOPurezza:Min. 95%Peso molecolare:173.6 g/mol2-(1-Chloroethyl)-5-methyl-1,3-oxazole
CAS:<p>Versatile small molecule scaffold</p>Formula:C6H8ClNOPurezza:Min. 95%Peso molecolare:145.59 g/mol(1-Methyl-2-oxo-butyl)-carbamic acid tert-butyl ester
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H19NO3Purezza:Min. 95%Peso molecolare:201.26 g/mol1-{1-[(tert-Butoxy)carbonyl]pyrrolidin-3-yl}-5-methyl-1H-1,2,3-triazole-4-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H20N4O4Purezza:Min. 95%Peso molecolare:296.32 g/mol7-Phenyl-3H-pyrimido[4,5-d]pyrimidin-4-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H8N4OPurezza:Min. 95%Peso molecolare:224.2 g/mol6-(Azetidin-1-yl)pyridine-3-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H10N2O2Purezza:Min. 95%Peso molecolare:178.19 g/mol3-(Piperidin-3-yl)butanoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H17NO2Purezza:Min. 95%Peso molecolare:171.24 g/mol6-(Methylsulfamoyl)pyridine-3-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H8N2O4SPurezza:Min. 95%Peso molecolare:216.22 g/mol6-Isopropoxynicotinamide
CAS:<p>6-Isopropoxynicotinamide is a drug that has shown efficacy in animal models for neurodegenerative diseases, such as prion diseases. It binds to specific proteins and inhibits the conformational change of the protein, thereby preventing the formation of amyloid plaques. This drug also prevents the conversion of alpha-helical proteins into beta-sheet structures, which are found in neuropathological conditions. 6-Isopropoxynicotinamide has been shown to have a pharmacokinetic profile that is long-term and effective at escalating doses, making it an ideal candidate for optimization against neurodegenerative diseases.</p>Formula:C9H12N2O2Purezza:Min. 95%Peso molecolare:180.2 g/moltert-Butyl 3-(1-amino-2-hydroxypropan-2-yl)piperidine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H26N2O3Purezza:Min. 95%Peso molecolare:258.4 g/mol2-Amino-6-methyl-5,6,7,8-tetrahydro-1,6-naphthyridine-3-carbonitrile
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H12N4Purezza:Min. 95%Peso molecolare:188.23 g/moltert-Butyl 4-(1-amino-2-hydroxypropan-2-yl)piperidine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H26N2O3Purezza:Min. 95%Peso molecolare:258.4 g/mol3-(1-{[(tert-Butoxy)carbonyl]amino}ethyl)-1,2-oxazole-4-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H16N2O5Purezza:Min. 95%Peso molecolare:256.25 g/mol1-{1-[(tert-Butoxy)carbonyl]pyrrolidin-3-yl}-1H-1,2,3-triazole-4-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H18N4O4Purezza:Min. 95%Peso molecolare:282.3 g/mol1-{1-[(tert-Butoxy)carbonyl]piperidin-3-yl}-1H-1,2,3-triazole-4-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H20N4O4Purezza:Min. 95%Peso molecolare:296.32 g/mol[1-(2-Methylpropyl)-1H-pyrazol-3-yl]methanamine
CAS:Versatile small molecule scaffoldFormula:C8H15N3Purezza:Min. 95%Peso molecolare:153.2 g/molBP 1-102
CAS:<p>BP 1-102 is a monoclonal antibody that targets PD-L1. It binds to PD-L1, blocking the interaction between PD-L1 and its ligands such as PD-1, B7-H3, and B7-H4. This prevents the inhibitory signals from reaching T cells and other immune cells, leading to an increase in T cell proliferation and activation. BP 1-102 has been shown to have minimal toxicity in animal studies. The drug was well tolerated with no significant changes in body weight or organ weight measurements. BP 1-102 also showed efficacy in preclinical models of cancer by inhibiting tumor growth and increasing cancer cell death (apoptosis). In addition, BP 1-102 has been shown to have an anti-inflammatory effect on IL17a production by T cells.</p>Formula:C29H27F5N2O6SPurezza:Min. 95%Peso molecolare:626.59 g/mol3-{1-[(tert-Butoxy)carbonyl]piperidin-3-yl}butanoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H25NO4Purezza:Min. 95%Peso molecolare:271.35 g/moltert-Butyl 2-propanoylpiperidine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H23NO3Purezza:Min. 95%Peso molecolare:241.33 g/moltert-Butyl 2-(1-aminoethyl)piperidine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H24N2O2Purezza:Min. 95%Peso molecolare:228.33 g/moltert-Butyl N-(3-aminobutan-2-yl)carbamate
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H20N2O2Purezza:Min. 95%Peso molecolare:188.27 g/moltert-Butyl (1-amino-1-phenylpropan-2-yl)carbamate
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H22N2O2Purezza:Min. 95%Peso molecolare:250.34 g/moltert-Butyl N-(1-amino-3-methyl-1-phenylbutan-2-yl)carbamate
CAS:<p>Versatile small molecule scaffold</p>Formula:C16H26N2O2Purezza:Min. 95%Peso molecolare:278.39 g/moltert-Butyl 4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)piperidine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H22F3NO3Purezza:Min. 95%Peso molecolare:297.31 g/mol3-{1-[(tert-Butoxy)carbonyl]piperidin-4-yl}butanoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H25NO4Purezza:Min. 95%Peso molecolare:271.35 g/moltert-Butyl 2-(1-hydroxyethyl)piperidine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H23NO3Purezza:Min. 95%Peso molecolare:229.32 g/mol6-[4-(2-Chlorophenyl)piperazin-1-yl]-2,3-dihydropyridazine-3-thione
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H15ClN4SPurezza:Min. 95%Peso molecolare:306.8 g/moltert-Butyl 4-(2,2-dimethylpropanoyl)piperidine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C15H27NO3Purezza:Min. 95%Peso molecolare:269.38 g/mol
